Price and states served both move. Read them off the seller's own site before you enroll.How our reviews work →

MEDVi vs Next Vial

MEDVi and Next Vial both sell semaglutide; this is how their prices, coverage and records differ.

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

By Ruth Calder · Enforcement Editor
Editorially reviewed & fact-checked against primary sources · How we verify contentLast reviewed
MEDVi logo

MEDVi

7.1
★★★★☆3.6/5

Best for: knowing which pharmacy fills the vial: it names Triad Rx

Visit MEDVi →
VS
Next Vial logo

Next Vial

5.7
★★★☆☆2.9/5

Best for: compounded semaglutide at $249.97/month

Visit Next Vial →

If you are choosing between MEDVi and Next Vial, price alone will not settle it. Both prescribe semaglutide, so moving from one to the other would not change your drug. MEDVi leads our six-part score, 7.1 to 5.7. One of the two has an FDA warning letter on record, covered below.

MEDVi vs Next Vial price

MEDVi and Next Vial start at within a dollar of each other ($249 and $249.97 a month), so the entry price does not separate them. Look at what each price covers and at the per-drug prices below.

Drug by drug: Semaglutide costs the same at both, $249 a month.

Medications and formats

Both sell semaglutide.

On format they match: each offers compounded injections.

Where each one treats patients

MEDVi lists 48 states, and Next Vial lists 49 states.

They overlap in 47 states. MEDVi alone covers Alaska. Next Vial alone covers Mississippi and North Dakota.

Pricing

MEDVi

Compounded GLP-1 Injection (weekly)Compounded
$299$179/mo
Save 40% right now
semaglutide

Refills are locked in at $299. The first month is $179 in the 'SUMMER Sale,' and some MEDVi landing pages offer the first month at $149.

Compounded GLP-1 Tablets (daily dissolvable)Compounded
$249/mo
semaglutide

Flat 'Starting at $249' — no intro discount shown.

Wegovy Pill / Wegovy Injection (membership fee only; medication cost not published)Brand-name
$99/mo
semaglutide

$99 Membership + Medication Cost — medication cost not published (varies/insurance may reimburse). 'Availability is subject to change.'

Zepbound Injection (membership fee only; medication cost not published)Brand-name
$99/mo
tirzepatide

$99 Membership + Medication Cost — medication cost not published. COMPOUNDED tirzepatide ($349 in our current entry) is no longer published anywhere on glp1.medvi.org, home.medvi.org, or the intake flow (0 mentions) — treat as discontinued/not published, do not carry the $349 row forward.

Next Vial

StandardCompounded
$249.97/mo
semaglutide

Starting monthly rate for GLP-1 program; tirzepatide rate not published.

What each price covers

Both prices cover the clinician visit, the medication itself and shipping.

MEDVi's price also covers coaching, which Next Vial does not claim.

MEDVi is silent on lab work.

Next Vial is silent on lab work and coaching.

MEDVi

Covered by the monthly price

Medication

In the price

Clinician visits

In the price

Shipping

In the price

Lab work

Not stated

Coaching

In the price

Next Vial

Covered by the monthly price

Medication

In the price

Clinician visits

In the price

Shipping

In the price

Lab work

Not stated

Coaching

Not stated

Where each one scores higher

Overall, MEDVi scores 7.1 and Next Vial 5.7 out of 10.

MEDVi is stronger on effectiveness (10.0 vs 8.5), user experience (8.0 vs 3.0), trust & safety (6.0 vs 5.0) and support (8.5 vs 7.0).

Value and accessibility are within half a point.

How we score

MEDVi

7.1/10

Overall

Next Vial

5.7/10

Value25%

2.8A
vs
B
2.8

Effectiveness25%

10.0A
vs
B
8.5

User Experience15%

8.0A
vs
B
3.0

Trust & Safety15%

6.0A
vs
B
5.0

Accessibility10%

9.7A
vs
B
9.8

Support10%

8.5A
vs
B
7.0

FDA warning letters

The FDA sent MEDVi a warning letter dated February 20, 2026 (letter 721455), and it is still open.

Next Vial has no FDA warning letter on record with us.

Features & Coverage

FeatureMEDViNext Vial
Starting Price✓$249/mo$249.97/mo
Features7 features7 features
States Available48✓49
Compounded✓ Yes✓ Yes
Brand Name✓ Yes—
FSA/HSA Accepted——
FDA Warning Letters1 letter✓None

About MEDVi

Two clinical groups do the treating at MEDVi: CareGLP Affiliated P.C.s, plus clinicians from OpenLoop Health. Its weight-loss menu holds compounded GLP-1s, injections and tablets alike, the molecule being semaglutide, next to Zepbound and Wegovy under their brand names. Licensed US pharmacies fill all of it.

Read our full MEDVi review →

About Next Vial

An online marketplace that connects patients to licensed providers for compounded semaglutide and tirzepatide injections, microdose options included. It is LegitScript verified and names its dispensing pharmacy: Manifest Pharmacy in Greer, SC. There is no membership required, and one price covers the consultation, the medication and free shipping. It serves 49 states.

Read our full Next Vial review →

Pros & Cons

MEDVi

What we like

  • Shows its price before the medical questionnaire, so you can compare it without handing over health information
  • The monthly price includes the medication, clinician visits, shipping and coaching
  • Serves 48 states
  • Names 3 pharmacies that fill its prescriptions, which most sellers do not

Watch-outs

  • Semaglutide costs $249 a month, 35% above the $184 median for compounded semaglutide across the sellers we compare
  • The FDA has issued MEDVi a warning letter. Read what it alleges: a letter flags a problem but does not by itself rule a seller out
  • Its semaglutide is compounded rather than FDA-approved, so it has not been reviewed by the agency for safety, effectiveness or manufacturing quality

Next Vial

What we like

  • The monthly price includes the medication, clinician visits and shipping
  • Serves 49 states
  • We found no FDA warning letters issued to Next Vial

Watch-outs

  • Semaglutide costs $249.97 a month, 36% above the $184 median for compounded semaglutide across the sellers we compare
  • You only see a price after finishing the medical intake, so you cannot compare costs before sharing health information
  • Ask which pharmacy fills the prescription before you pay, so you can check its license
  • Its semaglutide is compounded rather than FDA-approved, so it has not been reviewed by the agency for safety, effectiveness or manufacturing quality

Our Verdict

Winner: MEDVi

MEDVi wins this one, 7.1 to 5.7, above all for knowing which pharmacy fills the vial: it names Triad Rx. Next Vial fits better if compounded semaglutide at $249.97/month is your priority.

Choose MEDVi if…

You want knowing which pharmacy fills the vial: it names Triad Rx and an opening price near $249 a month.

Choose Next Vial if…

You want compounded semaglutide at $249.97/month and an opening price near $249.97 a month.

Ready to start? GLP-1 providers we have vetted

Telehealth providers, vetted by us, prescribing GLP-1 online.

Vetted by our editors · no insurance required

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

5.9

Wellorithm

Compounded semaglutide at $247/month

6.6

Willow

Seeing what it charges before you answer any medical questions

6.5

Sesame Care

Oral orforglipron alongside the injectables

MEDVi vs Next Vial: FAQ

Neither on the entry price: MEDVi and Next Vial both start at about $249 a month. The difference is in what the price includes.
Yes, both sell semaglutide.
Next Vial: 49 states against 48, with 47 in common.
Both include the clinician visit, the medication itself and shipping. Only MEDVi includes coaching.
MEDVi has an open FDA warning letter from February 20, 2026. Next Vial has none.
No. Neither MEDVi nor Next Vial pays us anything.

Or see the full category ranking.